These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 374734)

  • 1. Stimulation of lymphocyte reactivity by a low molecular weight cutaneous antigen in patients with progressive systemic sclerosis (scleroderma).
    Kondo H; Rabin BS; Rodnan GP
    J Rheumatol; 1979; 6(1):30-7. PubMed ID: 374734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
    Kondo H; Rabin BS; Rodnan GP
    J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma.
    Horwitz DA; Garrett MA
    Clin Exp Immunol; 1977 Jan; 27(1):92-9. PubMed ID: 300308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular immune phenomenon in scleroderma].
    Fritz J; Sandhofer M
    Dermatologica; 1977; 154(3):129-37. PubMed ID: 852625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired release of a T-cell specific suppressor factor in rheumatoid arthritis.
    Lau C; Budz-Tymkewycz S; Ramsden M; Lee P; Keystone EC
    Clin Exp Immunol; 1985 Sep; 61(3):489-95. PubMed ID: 3878238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral and cellular immunity in progressive systemic sclerosis.
    Sierakowski S; Bernacka K
    Med Interne; 1987; 25(4):233-8. PubMed ID: 3501150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
    van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
    Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of dominant T-cell clones in peripheral blood of patients with collagen vascular disorders: a prospective study of 97 cases.
    Dereure O; Gubler B; Bessis D; Guillot B; Guilhou JJ; Clot J; Eliaou JF
    Br J Dermatol; 2006 Mar; 154(3):445-9. PubMed ID: 16445773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histocompatibility antigens in progressive systemic sclerosis (scleroderma).
    Birnbaum NS; Rodnan GP; Rabin BS; Bassion S
    J Rheumatol; 1977; 4(4):425-8. PubMed ID: 604479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of HLA-B8 with visceral disease in systemic sclerosis.
    Hughes P; Gelsthorpe K; Doughty RW; Rowell NR; Rosenthal FD; Sneddon IB
    Clin Exp Immunol; 1978 Mar; 31(3):351-6. PubMed ID: 306903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro reactivity of lymphocytes obtained from patients with diffuse scleroderma].
    Onisk Z; Tchórzewski H
    Przegl Dermatol; 1975; 62(2):183-6. PubMed ID: 1079955
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis.
    Stuart JM; Postlethwaite AE; Kang AH
    J Lab Clin Med; 1976 Oct; 88(4):601-7. PubMed ID: 965811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of defective cell-mediated immunity to visceral disease in systemic sclerosis.
    Hughes P; Holt S; Rowell NR; Allonby ID; Janis K; Dodd JK
    Clin Exp Immunol; 1977 May; 28(2):233-40. PubMed ID: 301448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surface markers of peripheral blood T- and B-lymphocytes in patients with rheumatoid diseases].
    Stankaitene DI; Redaitene EI; Rulis AK; Ianulevichiute NA
    Ter Arkh; 1981; 53(7):6-11. PubMed ID: 7027511
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of circulating immunoblasts in the peripheral blood of patients with systemic lupus erythematosus and other rheumatic diseases].
    Bulanova TD; le Go A; Alekberova ZS; Polianskaia IP
    Ter Arkh; 1980; 52(6):64-7. PubMed ID: 6967635
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA-DR antigens in progressive systemic sclerosis (scleroderma).
    Whiteside TL; Medsger TA; Rodnan GP
    J Rheumatol; 1983 Feb; 10(1):128-31. PubMed ID: 6601709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
    Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
    Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma).
    Inoshita T; Whiteside TL; Rodnan GP; Taylor FH
    J Lab Clin Med; 1981 Feb; 97(2):264-77. PubMed ID: 6450255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.